A case of “ETV6-FISH-negative” secretory carcinoma of the parotid gland: immunohistochemical study

Medical Molecular Morphology - Tập 54 - Trang 296-300 - 2021
Hiroshi Harada1, Koji Irie2, Shin-ichi Nakatsuka3, Takakazu Sasaguri4, Keiichiro Honma5, Akira Kurose1
1Department of Anatomic Pathology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
2Department of Pathology, Fukuoka Tokushukai Hospital, Kasuga, Japan
3Department of Diagnostic Pathology, Sakai City Medical Center, Sakai, Japan
4Department of Diagnostic Pathology, Kitakyushu General Hospital, Kitakyushu, Japan
5Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan

Tóm tắt

Secretory carcinoma of the salivary glands is a relatively new disease concept, and is characterized by “morphological resemblance to mammary secretory carcinoma and ETV6–NTRK3 gene fusion.” Herein we describe a confusing case and briefly discuss practical diagnostic problems. The patient was a 71-year-old Japanese man who had a tumor consistent with secretory carcinoma at the microscopic and immunohistochemical levels. Immunohistochemically, EMA and S100 protein were noted to be positive along with various cytokeratins as well as mammaglobin and pSTAT5. Moreover, vimentin was focally positive. Smooth muscle actin, p63, p40, and androgen receptor were negative. However, a search using fluorescence in situ hybridization did not reveal a definite split signal for the ETV6 gene. It is presumed that confirming the diagnosis of secretory carcinoma without genetic retrieval will be accepted as a diagnostic method, and we hope that worldwide general recognition may earlier reach “gradual acceptance.”

Tài liệu tham khảo

Hamamoto Y, Harada H, Kohara M, Honma K, Nakatsuka SI, Morii E (2020) Usefulness of immunohistochemistry to distinguish between secretory carcinoma and acinic cell carcinoma in the salivary gland. Med Mol Morphol. https://doi.org/10.1007/s00795-020-00256-4. (epub ahead of print) Skálová A, Vanecek T, Simpson RH, Laco J, Majewska H, Baneckova M, Steiner P, Michal M (2016) Mammary analogue secretory carcinoma of salivary glands. Molecular analysis of 25 ETV6 gene rearranged tumors with lack of detection of classical ETV6–NTRK3 fusion transcript by standard RT-PCR: report of 4 cases harboring ETV6-X gene fusion. Am J Surg Pathol 40:3–13 Skalova A, Vanecek T, Martinek P, Weinreb I, Stevens TM, Simpson RHW, Hyrcza M, Rupp NJ, Baneckova M, Michal M Jr, Slouka D, Svoboda T, Metelkova A, Etebarian A, Pavelka J, Potts SJ, Christiansen J, Steiner P, Michal M (2018) Molecular profiling of mammary analog secretory carcinoma revealed a subset of tumors harboring a novel ETV6-RET translocation: report of 10 cases. Am J Surg Pathol 42:234–246 Rooper LM, Karantanos T, Ning Y, Bishop JA, Gordon SW, Kang H (2018) Salivary secretory carcinoma with a novel ETV6-MET fusion: expanding the molecular spectrum of a recently described entity. Am J Surg Pathol 42:1121–1126 Guilmette J, Dias-Santagata D, Nosé V, Lennerz JK, Sadow PM (2019) Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family. Hum Pathol 83:50–58 Shah AA, Wenig BM, LeGallo RD, Mills SE, Stelow EB (2015) Morphology in conjunction with immunohistochemistry is sufficient for the diagnosis of mammary analogue secretory carcinoma. Head Neck Pathol 9:85–95 Montalvo N, Galarza D, Redrobán L (2019) Secretory carcinoma of the parotid: making the correct diagnosis of a rare salivary gland carcinoma when molecular biology testing is not available. Case Rep Pathol 2019:5103496. https://doi.org/10.1155/2019/5103496 Skálová A, Banečkova M, Thompson LDR, Ptáková N, Stevens TM, Brcic L, Hyrcza M, Michal M Jr, Simpson RHW, Santana T, Michal M, Vaněček T, Leivo I (2020) Expanding the molecular spectrum of secretory carcinoma of salivary glands with a novel VIM-RET fusion. Am J Surg Pathol 44:1295–1307 Kawahara A, Taira T, Abe H, Takase Y, Kurita T, Sadashima E, Hattori S, Imamura I, Matsumoto S, Fujisaki H, Sueyoshi K, Akiba J, Kage M (2015) Diagnostic utility of phosphorylated signal transducer and activator of transcription 5 immunostaining in the diagnosis of mammary analogue secretory carcinoma of the salivary gland: a comparative study of salivary gland cancers. Cancer Cytopathol 123:603–611 Hung YP, Jo VY, Hornick JL (2019) Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma. Histopathology 75:54–62 Bell D, Ferrarotto R, Liang L, Goepfert RP, Li J, Ning J, Broaddus R, Weber RS, El-Naggar AK (2020) Pan-Trk immunohistochemistry reliably identifies ETV6–NTRK3 fusion in secretory carcinoma of the salivary gland. Virchows Arch 476:295–305